Loading…

Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites

Diallyl sulfide, a major flavor ingredient from garlic, was previously shown to inhibit chemically induced carcinogenesis and cytotoxicity in animal model systems. It modulated cytochrome P-450 compositions by inactivating P-450 2E1 and inducing P-450 2B1. The present studies examined the inhibition...

Full description

Saved in:
Bibliographic Details
Published in:Chemical research in toxicology 1991-11, Vol.4 (6), p.642-647
Main Authors: Brady, John F, Ishizaki, Hiroyuki, Fukuto, Jon M, Lin, Marie C, Fadel, Addi, Gapac, Jeanne M, Yang, Chung S
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a480t-e03f43a2a047ccceb2882d6df9638b3f6e5e7a03cf57ff5967bb957c6c169a13
cites
container_end_page 647
container_issue 6
container_start_page 642
container_title Chemical research in toxicology
container_volume 4
creator Brady, John F
Ishizaki, Hiroyuki
Fukuto, Jon M
Lin, Marie C
Fadel, Addi
Gapac, Jeanne M
Yang, Chung S
description Diallyl sulfide, a major flavor ingredient from garlic, was previously shown to inhibit chemically induced carcinogenesis and cytotoxicity in animal model systems. It modulated cytochrome P-450 compositions by inactivating P-450 2E1 and inducing P-450 2B1. The present studies examined the inhibition of P-450 2E1 mediated p-nitrophenol hydroxylase activity by diallyl sulfide and its putative metabolites diallyl sulfoxide and diallyl sulfone (DASO2). Each compound displayed competitive inhibition of p-nitrophenol hydroxylase activity in incubations using liver microsomes from acetone-pretreated male Sprague-Dawley rats. Preincubation of the microsomes with DASO2 inactivated p-nitrophenol hydroxylase activity in a process that was time- and NADPH-dependent and saturable, exhibited pseudo-first-order kinetics, was protected by alternate substrate, was accompanied by a loss of microsomal P-450-CO binding spectrum, and was unaffected by exogenous nucleophile. The Ki value for DASO2 was 188 microM and the maximal rate of inactivation was 0.32 min-1. DASO2 was ineffective in the inactivation of ethoxyresorufin dealkylase, pentoxyresorufin dealkylase, or benzphetamine demethylase activity. Purified P-450 2E1 in a reconstituted system was inactivated in a time- and NADPH-dependent manner by DASO2. The metabolic conversion of diallyl sulfide to the sulfoxide and sulfone was observed in vivo and in vitro. The results suggest that diallyl sulfide inhibits the metabolism of P-450 2E1 substrates by competitive inhibition mechanisms and by inactivating P-450 2E1 via a suicide-inhibitory action of DASO2.
doi_str_mv 10.1021/tx00024a008
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16103277</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16103277</sourcerecordid><originalsourceid>FETCH-LOGICAL-a480t-e03f43a2a047ccceb2882d6df9638b3f6e5e7a03cf57ff5967bb957c6c169a13</originalsourceid><addsrcrecordid>eNpt0E1rFTEUBuAglnqtrlwLWYguZOpJMvmYpdRWLxTa0rvoLmQyCU3NTGqSgd5_78hcqgtXZ_E-53B4EXpH4JQAJV_qEwDQ1gCoF2hDOIWGA4GXaAOqYw2l6u4Vel3KAwBZFuQxOiYKZNvKDdpup_vQhxrShJPHdl-Tvc9pdPi6aTlgek5wv8dDMDHuIy5z9GFw2EwDDrXg0VXTpxiqK2_QkTexuLeHeYJ2F-e7sx_N5dX37dnXy8a0CmrjgPmWGWqgldZa11Ol6CAG3wmmeuaF404aYNZz6T3vhOz7jksrLBGdIewEfVzPPub0a3al6jEU62I0k0tz0UQQYFTKBX5eoc2plOy8fsxhNHmvCeg_vel_elv0-8PZuR_d8NeuRS35h0NuijXRZzPZUJ4ZJ4QKLhbWrCyU6p6eY5N_aiGZ5Hp3fatvxJ1UtxdEf1v8p9UbW_RDmvO0VPffB38DehCPFA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16103277</pqid></control><display><type>article</type><title>Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites</title><source>ACS CRKN Legacy Archives</source><creator>Brady, John F ; Ishizaki, Hiroyuki ; Fukuto, Jon M ; Lin, Marie C ; Fadel, Addi ; Gapac, Jeanne M ; Yang, Chung S</creator><creatorcontrib>Brady, John F ; Ishizaki, Hiroyuki ; Fukuto, Jon M ; Lin, Marie C ; Fadel, Addi ; Gapac, Jeanne M ; Yang, Chung S</creatorcontrib><description>Diallyl sulfide, a major flavor ingredient from garlic, was previously shown to inhibit chemically induced carcinogenesis and cytotoxicity in animal model systems. It modulated cytochrome P-450 compositions by inactivating P-450 2E1 and inducing P-450 2B1. The present studies examined the inhibition of P-450 2E1 mediated p-nitrophenol hydroxylase activity by diallyl sulfide and its putative metabolites diallyl sulfoxide and diallyl sulfone (DASO2). Each compound displayed competitive inhibition of p-nitrophenol hydroxylase activity in incubations using liver microsomes from acetone-pretreated male Sprague-Dawley rats. Preincubation of the microsomes with DASO2 inactivated p-nitrophenol hydroxylase activity in a process that was time- and NADPH-dependent and saturable, exhibited pseudo-first-order kinetics, was protected by alternate substrate, was accompanied by a loss of microsomal P-450-CO binding spectrum, and was unaffected by exogenous nucleophile. The Ki value for DASO2 was 188 microM and the maximal rate of inactivation was 0.32 min-1. DASO2 was ineffective in the inactivation of ethoxyresorufin dealkylase, pentoxyresorufin dealkylase, or benzphetamine demethylase activity. Purified P-450 2E1 in a reconstituted system was inactivated in a time- and NADPH-dependent manner by DASO2. The metabolic conversion of diallyl sulfide to the sulfoxide and sulfone was observed in vivo and in vitro. The results suggest that diallyl sulfide inhibits the metabolism of P-450 2E1 substrates by competitive inhibition mechanisms and by inactivating P-450 2E1 via a suicide-inhibitory action of DASO2.</description><identifier>ISSN: 0893-228X</identifier><identifier>EISSN: 1520-5010</identifier><identifier>DOI: 10.1021/tx00024a008</identifier><identifier>PMID: 1807447</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Allyl Compounds - pharmacology ; Animals ; Biological and medical sciences ; Carcinogenesis, carcinogens and anticarcinogens ; Cytochrome P-450 CYP2E1 ; Cytochrome P-450 Enzyme Inhibitors ; General aspects ; Male ; Medical sciences ; Mixed Function Oxygenases - antagonists &amp; inhibitors ; Rats ; Rats, Inbred Strains ; Sulfides - metabolism ; Sulfides - pharmacology ; Sulfones - pharmacology ; Sulfoxides - pharmacology ; Tumors</subject><ispartof>Chemical research in toxicology, 1991-11, Vol.4 (6), p.642-647</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a480t-e03f43a2a047ccceb2882d6df9638b3f6e5e7a03cf57ff5967bb957c6c169a13</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/tx00024a008$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/tx00024a008$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,27064,27924,27925,56766,56816</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5112656$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1807447$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brady, John F</creatorcontrib><creatorcontrib>Ishizaki, Hiroyuki</creatorcontrib><creatorcontrib>Fukuto, Jon M</creatorcontrib><creatorcontrib>Lin, Marie C</creatorcontrib><creatorcontrib>Fadel, Addi</creatorcontrib><creatorcontrib>Gapac, Jeanne M</creatorcontrib><creatorcontrib>Yang, Chung S</creatorcontrib><title>Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites</title><title>Chemical research in toxicology</title><addtitle>Chem. Res. Toxicol</addtitle><description>Diallyl sulfide, a major flavor ingredient from garlic, was previously shown to inhibit chemically induced carcinogenesis and cytotoxicity in animal model systems. It modulated cytochrome P-450 compositions by inactivating P-450 2E1 and inducing P-450 2B1. The present studies examined the inhibition of P-450 2E1 mediated p-nitrophenol hydroxylase activity by diallyl sulfide and its putative metabolites diallyl sulfoxide and diallyl sulfone (DASO2). Each compound displayed competitive inhibition of p-nitrophenol hydroxylase activity in incubations using liver microsomes from acetone-pretreated male Sprague-Dawley rats. Preincubation of the microsomes with DASO2 inactivated p-nitrophenol hydroxylase activity in a process that was time- and NADPH-dependent and saturable, exhibited pseudo-first-order kinetics, was protected by alternate substrate, was accompanied by a loss of microsomal P-450-CO binding spectrum, and was unaffected by exogenous nucleophile. The Ki value for DASO2 was 188 microM and the maximal rate of inactivation was 0.32 min-1. DASO2 was ineffective in the inactivation of ethoxyresorufin dealkylase, pentoxyresorufin dealkylase, or benzphetamine demethylase activity. Purified P-450 2E1 in a reconstituted system was inactivated in a time- and NADPH-dependent manner by DASO2. The metabolic conversion of diallyl sulfide to the sulfoxide and sulfone was observed in vivo and in vitro. The results suggest that diallyl sulfide inhibits the metabolism of P-450 2E1 substrates by competitive inhibition mechanisms and by inactivating P-450 2E1 via a suicide-inhibitory action of DASO2.</description><subject>Allyl Compounds - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>Cytochrome P-450 CYP2E1</subject><subject>Cytochrome P-450 Enzyme Inhibitors</subject><subject>General aspects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mixed Function Oxygenases - antagonists &amp; inhibitors</subject><subject>Rats</subject><subject>Rats, Inbred Strains</subject><subject>Sulfides - metabolism</subject><subject>Sulfides - pharmacology</subject><subject>Sulfones - pharmacology</subject><subject>Sulfoxides - pharmacology</subject><subject>Tumors</subject><issn>0893-228X</issn><issn>1520-5010</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNpt0E1rFTEUBuAglnqtrlwLWYguZOpJMvmYpdRWLxTa0rvoLmQyCU3NTGqSgd5_78hcqgtXZ_E-53B4EXpH4JQAJV_qEwDQ1gCoF2hDOIWGA4GXaAOqYw2l6u4Vel3KAwBZFuQxOiYKZNvKDdpup_vQhxrShJPHdl-Tvc9pdPi6aTlgek5wv8dDMDHuIy5z9GFw2EwDDrXg0VXTpxiqK2_QkTexuLeHeYJ2F-e7sx_N5dX37dnXy8a0CmrjgPmWGWqgldZa11Ol6CAG3wmmeuaF404aYNZz6T3vhOz7jksrLBGdIewEfVzPPub0a3al6jEU62I0k0tz0UQQYFTKBX5eoc2plOy8fsxhNHmvCeg_vel_elv0-8PZuR_d8NeuRS35h0NuijXRZzPZUJ4ZJ4QKLhbWrCyU6p6eY5N_aiGZ5Hp3fatvxJ1UtxdEf1v8p9UbW_RDmvO0VPffB38DehCPFA</recordid><startdate>19911101</startdate><enddate>19911101</enddate><creator>Brady, John F</creator><creator>Ishizaki, Hiroyuki</creator><creator>Fukuto, Jon M</creator><creator>Lin, Marie C</creator><creator>Fadel, Addi</creator><creator>Gapac, Jeanne M</creator><creator>Yang, Chung S</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>19911101</creationdate><title>Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites</title><author>Brady, John F ; Ishizaki, Hiroyuki ; Fukuto, Jon M ; Lin, Marie C ; Fadel, Addi ; Gapac, Jeanne M ; Yang, Chung S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a480t-e03f43a2a047ccceb2882d6df9638b3f6e5e7a03cf57ff5967bb957c6c169a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Allyl Compounds - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>Cytochrome P-450 CYP2E1</topic><topic>Cytochrome P-450 Enzyme Inhibitors</topic><topic>General aspects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mixed Function Oxygenases - antagonists &amp; inhibitors</topic><topic>Rats</topic><topic>Rats, Inbred Strains</topic><topic>Sulfides - metabolism</topic><topic>Sulfides - pharmacology</topic><topic>Sulfones - pharmacology</topic><topic>Sulfoxides - pharmacology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brady, John F</creatorcontrib><creatorcontrib>Ishizaki, Hiroyuki</creatorcontrib><creatorcontrib>Fukuto, Jon M</creatorcontrib><creatorcontrib>Lin, Marie C</creatorcontrib><creatorcontrib>Fadel, Addi</creatorcontrib><creatorcontrib>Gapac, Jeanne M</creatorcontrib><creatorcontrib>Yang, Chung S</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Chemical research in toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brady, John F</au><au>Ishizaki, Hiroyuki</au><au>Fukuto, Jon M</au><au>Lin, Marie C</au><au>Fadel, Addi</au><au>Gapac, Jeanne M</au><au>Yang, Chung S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites</atitle><jtitle>Chemical research in toxicology</jtitle><addtitle>Chem. Res. Toxicol</addtitle><date>1991-11-01</date><risdate>1991</risdate><volume>4</volume><issue>6</issue><spage>642</spage><epage>647</epage><pages>642-647</pages><issn>0893-228X</issn><eissn>1520-5010</eissn><abstract>Diallyl sulfide, a major flavor ingredient from garlic, was previously shown to inhibit chemically induced carcinogenesis and cytotoxicity in animal model systems. It modulated cytochrome P-450 compositions by inactivating P-450 2E1 and inducing P-450 2B1. The present studies examined the inhibition of P-450 2E1 mediated p-nitrophenol hydroxylase activity by diallyl sulfide and its putative metabolites diallyl sulfoxide and diallyl sulfone (DASO2). Each compound displayed competitive inhibition of p-nitrophenol hydroxylase activity in incubations using liver microsomes from acetone-pretreated male Sprague-Dawley rats. Preincubation of the microsomes with DASO2 inactivated p-nitrophenol hydroxylase activity in a process that was time- and NADPH-dependent and saturable, exhibited pseudo-first-order kinetics, was protected by alternate substrate, was accompanied by a loss of microsomal P-450-CO binding spectrum, and was unaffected by exogenous nucleophile. The Ki value for DASO2 was 188 microM and the maximal rate of inactivation was 0.32 min-1. DASO2 was ineffective in the inactivation of ethoxyresorufin dealkylase, pentoxyresorufin dealkylase, or benzphetamine demethylase activity. Purified P-450 2E1 in a reconstituted system was inactivated in a time- and NADPH-dependent manner by DASO2. The metabolic conversion of diallyl sulfide to the sulfoxide and sulfone was observed in vivo and in vitro. The results suggest that diallyl sulfide inhibits the metabolism of P-450 2E1 substrates by competitive inhibition mechanisms and by inactivating P-450 2E1 via a suicide-inhibitory action of DASO2.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>1807447</pmid><doi>10.1021/tx00024a008</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0893-228X
ispartof Chemical research in toxicology, 1991-11, Vol.4 (6), p.642-647
issn 0893-228X
1520-5010
language eng
recordid cdi_proquest_miscellaneous_16103277
source ACS CRKN Legacy Archives
subjects Allyl Compounds - pharmacology
Animals
Biological and medical sciences
Carcinogenesis, carcinogens and anticarcinogens
Cytochrome P-450 CYP2E1
Cytochrome P-450 Enzyme Inhibitors
General aspects
Male
Medical sciences
Mixed Function Oxygenases - antagonists & inhibitors
Rats
Rats, Inbred Strains
Sulfides - metabolism
Sulfides - pharmacology
Sulfones - pharmacology
Sulfoxides - pharmacology
Tumors
title Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T14%3A33%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20cytochrome%20P-450%202E1%20by%20diallyl%20sulfide%20and%20its%20metabolites&rft.jtitle=Chemical%20research%20in%20toxicology&rft.au=Brady,%20John%20F&rft.date=1991-11-01&rft.volume=4&rft.issue=6&rft.spage=642&rft.epage=647&rft.pages=642-647&rft.issn=0893-228X&rft.eissn=1520-5010&rft_id=info:doi/10.1021/tx00024a008&rft_dat=%3Cproquest_cross%3E16103277%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a480t-e03f43a2a047ccceb2882d6df9638b3f6e5e7a03cf57ff5967bb957c6c169a13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16103277&rft_id=info:pmid/1807447&rfr_iscdi=true